Advertisement

WHO ending hydroxychloroquine trial for COVID

This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. Photo: John Locher/Associated Press. This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas.

The Associated Press
Created: July 04, 2020 04:12 PM

The World Health Organization says it is ending a trial into whether anti-malaria drug hydroxychloroquine helps patients hospitalized with COVID-19.

WHO said Saturday it has “accepted the recommendation” from the committee overseeing the trial to discontinue testing of hydroxychloroquine and lopinavir/ritonavir, a drug combination used to treat HIV/AIDS. The drugs were being compared with standard care for hospitalized patients.

Advertisement

WHO says a review of the interim results showed hydroxychloroquine and lopinavir/ritonavir “produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care.”

The agency adds that while there was no “solid evidence” of increased mortality for hospitalized patients given the drugs, there were “some associated safety signals in the clinical laboratory findings” of an associated trial.


Copyright 2020 - KSTP-TV, LLC A Hubbard Broadcasting Company

Comment on Facebook
Advertisement

Officers' body camera video in George Floyd case released to public

Trump abruptly escorted from briefing after shooting near White House

What voters need to know before Tuesday's primary

Warm, dry weather expected following through the week

Advertisement